Eton Pharmaceuticals Inc (ETON)
11.17
+0.42
(+3.91%)
USD |
NASDAQ |
Nov 22, 15:57
Eton Pharmaceuticals Total Liabilities (Quarterly): 19.86M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.86M |
| June 30, 2024 | 18.36M |
| March 31, 2024 | 15.30M |
| December 31, 2023 | 16.26M |
| September 30, 2023 | 14.63M |
| June 30, 2023 | 14.21M |
| March 31, 2023 | 12.69M |
| December 31, 2022 | 11.95M |
| September 30, 2022 | 10.34M |
| June 30, 2022 | 9.804M |
| March 31, 2022 | 9.813M |
| December 31, 2021 | 9.835M |
| September 30, 2021 | 10.95M |
| June 30, 2021 | 9.17M |
| Date | Value |
|---|---|
| March 31, 2021 | 9.631M |
| December 31, 2020 | 10.66M |
| September 30, 2020 | 10.01M |
| June 30, 2020 | 7.528M |
| March 31, 2020 | 6.621M |
| December 31, 2019 | 6.522M |
| September 30, 2019 | 1.159M |
| June 30, 2019 | 1.545M |
| March 31, 2019 | 3.775M |
| December 31, 2018 | 2.024M |
| September 30, 2018 | 2.774M |
| June 30, 2018 | 2.15M |
| March 31, 2018 | 1.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.522M
Minimum
Dec 2019
19.86M
Maximum
Sep 2024
11.71M
Average
10.50M
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Integra Lifesciences Holdings Corp | 2.544B |
| Elutia Inc | 88.64M |
| Immuneering Corp | 10.84M |
| Journey Medical Corp | 53.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 35.84M |
| Shareholders Equity (Quarterly) | 15.98M |
| Debt to Equity Ratio | 0.2581 |
| Current Ratio | 1.508 |
| Net Debt Paydown Yield | 0.25% |